Inhibition of PCSK9 in familial hypercholesterolaemia

被引：5
|
作者：
Sijbrands, Eric J. G. [1 ,2 ]
机构：
[1] Erasmus MC, Pharmacol Vasc & Metab Dis sect, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Cardiol & Internal Med, Cardiovasc Genet Sect, NL-3000 CA Rotterdam, Netherlands
来源：
LANCET | 2012年 / 380卷 / 9836期
关键词：
APOLIPOPROTEIN-B; CONTROLLED-TRIAL; LDL CHOLESTEROL; DOUBLE-BLIND; STATIN; ATHEROSCLEROSIS; MIPOMERSEN; EZETIMIBE; EFFICACY; THERAPY;
D O I：
10.1016/S0140-6736(12)60814-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [21] PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia Useful But Seldom Sufficient
    Thompson, Gilbert R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (02) : 143 - 145
  • [22] PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9
    Tavori, Hagai
    Giunzioni, Ilaria
    Fazio, Sergio
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2015, 22 (02) : 126 - 132
  • [23] PCSK9 inhibition for autosomal recessive hypercholesterolemia
    Chemello, Kevin
    Martin, Cesar
    Lambert, Gilles
    ATHEROSCLEROSIS, 2019, 284 : 209 - 211
  • [24] Reduction of Low-Density Lipoprotein Cholesterol by Monoclonal Antibody Inhibition of PCSK9
    Stein, Evan A.
    Raal, Frederick
    ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 : 417 - 431
  • [25] PCSK9 inhibition in patients with hypercholesterolemia
    Desai, Nihar R.
    Sabatine, Marc S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 567 - 574
  • [26] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [27] Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias
    Rached, Fabiana
    Santos, Raul D.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [28] PCSK9-Hemmung – ein UpdateUpdate on PCSK9 inhibition
    Julius L. Katzmann
    Florian Custodis
    Stephan H. Schirmer
    Ulrich Laufs
    Herz, 2022, 47 : 196 - 203
  • [29] PCSK9 Inhibition The Next Statin?
    Vogel, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (25) : 2354 - 2355
  • [30] PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
    Katzmann, Julius L.
    Gouni-Berthold, Ioanna
    Laufs, Ulrich
    FRONTIERS IN PHYSIOLOGY, 2020, 11
12345